Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 22

Trial Status

Completed3
Other3

Role Distribution

Principal Investigator6
PI Rate100%

Activity Timeline

Clinical Trials (6)

NCT03631017Phase 1/2Active Not Recruiting
Imaging With a PET Agent for Detection of Cancers of the Head and Neck
Head and Neck Cancer
PrincipalinvestigatorStart date: 2018-08-10
NCT03204123Phase 2Active Not Recruiting
PSMA PET Imaging of Recurrent Prostate Cancer
Prostate AdenocarcinomaProstate Cancer
PrincipalinvestigatorStart date: 2017-06-26
NCT01474577Completed
Prognostic Value of Rb-82 PET Myocardial Perfusion Imaging
Cardiac Health
PrincipalinvestigatorStart date: 2011-11-08
NCT00605488Not ApplicableCompleted
The Biodistribution and Potential Diagnostic Ability of 18F FACBC in Patients With Head and Neck, Breast, and Prostate Cancer
Breast CancerHead and Neck CancerProstate Cancer
Principalinvestigator
NCT02139150Not ApplicableWithdrawn
Serial FLT PET Imaging in Cancer Patients for Monitoring of Response to Therapy
Histologically-confirmed Malignancies
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

John D. Hainsworth, MD

SCRI Development Innovations, LLC

Related
26 trials

Shared therapeutic areas:

Prostate CancerBreast CancerCancer of Kidney+1 more
Similarity Score10%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Breast CancerCancer of the Uterine CervixCancer of Head and Neck+1 more
Similarity Score10%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Breast CancerCancer of the Uterine CervixCancer of Kidney

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Aminah Jatoi, MD

Mayo Clinic

Related
29 trials

Shared therapeutic areas:

Prostate CancerBreast CancerCancer of Head and Neck

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Prostate CancerProstate AdenocarcinomaCancer of Kidney

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

Related
21 trials

Shared therapeutic areas:

Breast CancerCancer of the Uterine CervixCancer of Head and Neck
Similarity Score8%

Mark Levine, MD

Ontario Clinical Oncology Group (OCOG)

Related
13 trials

Shared therapeutic areas:

Breast CancerProstate CancerCancer of Head and Neck
Similarity Score8%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Breast CancerProstate Cancer
Similarity Score5%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Cancer of Head and NeckProstate Cancer
Similarity Score5%

Steven A. Rosenberg, MD, PhD

NCI - Surgery Branch

Related
29 trials

Shared therapeutic areas:

Cancer of KidneyBreast Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (6)

Showing 6 of 6 trials

NCT03631017Phase 1/2PrincipalInvestigator

Imaging With a PET Agent for Detection of Cancers of the Head and Neck

Head and Neck Cancer
Active Not Recruiting
NCT03204123Phase 2PrincipalInvestigator

PSMA PET Imaging of Recurrent Prostate Cancer

Prostate AdenocarcinomaProstate Cancer
Active Not Recruiting
NCT01474577PrincipalInvestigator

Prognostic Value of Rb-82 PET Myocardial Perfusion Imaging

Cardiac Health
Completed
NCT00588276Phase 1PrincipalInvestigator

Pilot Evaluation of 124I-Iodo-Azomycin Galacto-Pyranoside (*IAZGP) Positron Emission Tomography (PET) in the Imaging of Hypoxic Tumors

Cervical CancerCERVIX UTERI NOSHEENT Cancer+3 more
Completed
NCT00605488Not ApplicablePrincipalInvestigator

The Biodistribution and Potential Diagnostic Ability of 18F FACBC in Patients With Head and Neck, Breast, and Prostate Cancer

Breast CancerHead and Neck CancerProstate Cancer
Completed
NCT02139150Not ApplicablePrincipalInvestigator

Serial FLT PET Imaging in Cancer Patients for Monitoring of Response to Therapy

Histologically-confirmed Malignancies
Withdrawn

All 6 trials loaded